SHANDONG LUKANG PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.79 CNY | -1.02% |
|
-10.46% | +9.10% |
| 29/05 | China Approves Lukang Pharma's Anti-Asthma Injection | MT |
| 23/04 | Shandong Lukang Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 964M | - | - | - | - | - | |
| 739B | ||||||
| 598B | ||||||
| 353B | ||||||
| 318B | ||||||
| 285B |
